Patents by Inventor Jerry Schneider

Jerry Schneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IRRIGATION DEVICES, METHODS, AND SYSTEMS
    Publication number: 20240108797
    Abstract: Irrigation devices, methods, and systems are disclosed. The system comprises a catheter with one or more lumens and an expandable portion. One or more pumps are used to supply a mixture of contrasting and dilating agents in an interior kidney volume and flush a portion of the mixture out of the interior kidney volume. The method comprises placing a catheter into the interior kidney volume through a ureter, occluding a portion of the ureter with a distal end of the catheter, forming an exit port through an exterior kidney surface, flowing the contrasting and dilating agents through the one or more lumens to supply the mixture in the interior kidney volume, and flushing a portion of the mixture out of the exit port.
    Type: Application
    Filed: December 12, 2023
    Publication date: April 4, 2024
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Jerry LONG, Timothy HARRAH, Aaron KIRKEMO, Brandon CRAFT, Elizabeth STOKLEY, Sebastian KOERNER, Chad SCHNEIDER
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 11311507
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: April 26, 2022
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20200338033
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: November 14, 2019
    Publication date: October 29, 2020
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 10485774
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: November 26, 2019
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
    Patent number: 10307386
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: June 4, 2019
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20190060264
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: March 15, 2018
    Publication date: February 28, 2019
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9925156
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: March 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9925158
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: March 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9925157
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: March 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9814689
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: November 14, 2017
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20170319524
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20170319522
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20170319523
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • METHODS OF TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) USING CYSTEAMINE PRODUCTS
    Publication number: 20170304233
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: November 28, 2016
    Publication date: October 26, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9795578
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: October 24, 2017
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9750708
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: September 5, 2017
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20170042845
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: October 27, 2016
    Publication date: February 16, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9511039
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: December 6, 2016
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
    Patent number: 9511038
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Grant
    Filed: September 28, 2015
    Date of Patent: December 6, 2016
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20160331691
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 29, 2016
    Publication date: November 17, 2016
    Inventors: Ranjan Dohil, Jerry Schneider